Background:

Cefuroxime Axetil 500 mg + Clavulanic Acid 125 mg, a broad-spectrum antibiotic combination used for treating moderate to severe bacterial infections, especially those resistant to ordinary cephalosporins or penicillins.

a) Cefuroxime Axetil – 500 mg

A second-generation cephalosporin antibiotic.

Mechanism: Inhibits bacterial cell wall synthesis, leading to cell death.

Effective against both Gram-positive and Gram-negative organisms.

Active against Streptococcus pneumoniae, Staphylococcus aureus (non-MRSA), E. coli, Klebsiella, Haemophilus influenzae, Neisseria, etc.

b) Clavulanic Acid – 125 mg

A β-lactamase inhibitor.

Protects cefuroxime from being broken down by β-lactamase-producing bacteria, thereby extending its spectrum.

Description

Cefuroxime Axetil 500 mg + Clavulanic Acid 125 mg Tablets

 Your Partner in Infection Management

Key Benefits:

  • Right Amount of Power – Combines broad-spectrum Cefuroxime with Clavulanic Acid, a β-lactamase inhibitor.
  • Convenient Oral Therapy – Enhances patient compliance.
  • Overcomes Bacterial Resistance – Active against β-lactamase producing strains.
  • High Clinical Success Rates – Trusted in both hospital and outpatient settings.
  • Ensures Power of Synergy – Potent dual-action for complete bacterial kill.
  • Target-Specific Action – Effective against a wide range of Gram-positive & Gram-negative organisms.

 Indications:

  • Post-Operative Infections
  • Skin & Soft Tissue Infections
  • Respiratory Tract Infections
  • Urinary Tract Infections (UTIs)
  • Bone & Joint Infections
  • Typhoid Fever

 Presentation:

Alu-Alu pack of 10 tablets

 Dosage:

1 tablet twice daily (every 12 hours), or as directed by the physician.
To be taken preferably after meals to enhance absorption and reduce GI discomfort.

 Kill Completely. Act Precisely. Trust the Synergy of ROFUXA®-CV.

Reviews

There are no reviews yet.

Be the first to review “ROFUXA CV”

Your email address will not be published. Required fields are marked *